AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 49 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $683,000 | -35.8% | 257,613 | +241.1% | 0.09% | -42.0% |
| Q1 2018 | $1,064,000 | +19.8% | 75,535 | 0.0% | 0.16% | +55.8% |
| Q4 2017 | $888,000 | -17.2% | 75,535 | 0.0% | 0.10% | -32.0% |
| Q3 2017 | $1,072,000 | +22.7% | 75,535 | +21.7% | 0.15% | +3.4% |
| Q2 2017 | $874,000 | -50.9% | 62,085 | -67.3% | 0.15% | -66.3% |
| Q2 2014 | $1,780,000 | -26.4% | 190,000 | 0.0% | 0.44% | -20.5% |
| Q1 2014 | $2,419,000 | – | 190,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 877,753 | $11,727,000 | 5.26% |
| RA Capital Management | 2,191,977 | $29,285,000 | 3.02% |
| NEXTHERA CAPITAL LP | 340,000 | $4,542,000 | 2.79% |
| Opaleye Management Inc. | 310,000 | $4,142,000 | 2.17% |
| Baker Brothers Advisors | 10,536,092 | $140,762,000 | 1.28% |
| Ghost Tree Capital, LLC | 250,000 | $3,340,000 | 0.54% |
| Cormorant Asset Management, LP | 151,838 | $2,029,000 | 0.22% |
| DAFNA Capital Management LLC | 20,000 | $267,000 | 0.19% |
| ELLINGTON MANAGEMENT GROUP LLC | 10,800 | $144,000 | 0.04% |
| Alyeska Investment Group, L.P. | 272,163 | $3,636,000 | 0.03% |